{
  "ptid_time": "009_S_2381_2011-05-18",
  "img_path": "/data/qiuhui/data/adni/images/009_S_2381/2011-05-18/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 31,394 mm³, 4.6% above the reference mean. With a Z-score of 0.11 (54.3th percentile), this represents normal volume ; hippocampal volume measures 5,834 mm³, 27.3% below the reference mean. With a Z-score of -2.73 (0.3th percentile), this represents significant atrophy; whole brain volume measures 1,168,450 mm³, 3.0% above the reference mean. With a Z-score of 0.42 (66.4th percentile), this represents normal volume ; entorhinal cortex volume measures 3,341 mm³, 21.6% below the reference mean. With a Z-score of -1.50 (6.7th percentile), this represents mild atrophy; fusiform gyrus volume measures 21,353 mm³, 7.3% above the reference mean. With a Z-score of 0.60 (72.7th percentile), this represents normal volume ; middle temporal gyrus volume measures 23,225 mm³, 3.6% above the reference mean. With a Z-score of 0.30 (61.8th percentile), this represents normal volume . ",
  "text_data": "Age is 69.1 years. Gender is Male. Education: 16 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Smoking; Major Surgical Procedures. MMSE: 28.0. MoCA: 23.0. Logical Memory: 9.0. Laboratory findings: MCHC: 37.00 (significant elevated); Total Bilirubin: 0.80 (significant elevated); Cholesterol (High Performance): 266.00 (significant elevated). APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.34 SUVR (significant elevated); Amyloid beta: 684.70 pg/mL (normal ); Total tau: 576.90 pg/mL (profound elevated); Phosphorylated tau: 57.70 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient exhibits significant hippocampal atrophy (Z-score -2.73) and mild entorhinal cortex atrophy (Z-score -1.50), both key regions affected in Alzheimer's disease. Despite normal Aβ levels, profoundly elevated T-tau and P-tau, along with significant AV45 (amyloid PET) positivity, strongly suggest Alzheimer's pathology. The MoCA score of 23 indicates mild cognitive impairment, while the MMSE of 28 is borderline normal, reflecting early-stage cognitive decline.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI) due to Alzheimer’s disease**  \n**Confidence:** **High** (due to clear biomarker evidence of neurodegeneration and tauopathy despite normal Aβ, along with structural atrophy in AD-vulnerable regions)",
  "timestamp": "2025-07-25T22:17:04.787279"
}